BenevolentAI

BenevolentAI is a technology company that uses artificial intelligence to accelerate drug discovery and development. They combine machine learning with scientific expertise to analyze vast amounts of biomedical data, identify potential drug targets, and predict drug candidates.

Cloud Pharmaceuticals

Cloud Pharmaceuticals is a biotechnology company that leverages advanced AI and cloud computing technology to accelerate drug discovery and development. They focus on using Generative AI to improve the efficiency of various stages in the pharmaceutical process, including target identification, lead optimization, and clinical trial management.

BPGbio

BPGbio is a clinical-stage biopharmaceutical company that utilizes artificial intelligence to develop therapies targeting mitochondrial biology and protein homeostasis. Their proprietary platform integrates a vast biobank with advanced AI to identify drug and diagnostic targets across oncology, neurology, and rare diseases.

BenchSci

BenchSci focuses on helping scientists speed up biomedical research by using AI to analyze scientific data. Their platform organizes and interprets published data on experiments, making it easier for researchers to find precise reagents and plan their studies. 

Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that focuses on discovering and developing novel small molecule therapies for complex diseases. The company uses its proprietary platform combines artificial intelligence (AI) and biomedical data, to accelerate drug discovery and increase success rates in pharmaceutical research and development.

Atomwise

Atomwise is a biotechnology company that leverages artificial intelligence to accelerate drug discovery, focusing on developing small-molecule therapies. Using convolutional neural networks and vast chemical libraries, Atomwise’s technology identifies promising drug candidates with high precision.